20986 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Corticotropin releasing factor [CRF] (Urotensin)
CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY
#2METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#3NOVEL FATTY ACID MODIFIED UROCORTIN 2 DERIVATIVES AND THE USES THEREOF
#4METHOD FOR PREVENTING OR TREATING HEART FAILURE BY ADMINISTERING A MEDICAMENT CONTAINING AN ANTAGONIST OF CORTICOTROPIN RELEASING HORMONE RECEPTOR 2 (CRHR2)
#5INTRANASAL ADMINISTRATION
#6Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer
#7Method of treating type I diabetes using an AAV vector encoding uracortin 2
#8SYNTHETIC BACTERIA AND METHODS OF USE
#9METHODS FOR DETERMINING WHETHER A PATIENT IS LIKELY TO BENEFIT FROM TREATMENT WITH A THERAPEUTIC FORMULATION
#10Method for preventing or treating heart failure by administering a medicament containing an antagonist of corticotropin releasing hormone receptor 2 (CRHR2)
#11INTRANASAL ADMINISTRATION
#12METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS
#13UROCORTIN 2 ANALOGS AND USES THEREOF
#14Formulation Comprising A Stabilized Complex Of Corticotropin Releasing Hormone And Alpha-2 Macroglobulin
#15CXCR4 binding molecules and methods of use thereof
#16Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease
#17Method of treating type I diabetes using an AAV vector encoding uracortin 2
#18COMPOSITIONS AND METHODS FOR TREATING PITUITARY TUMORS
#19SYSTEMIC DELIVERY OF VIRUS VECTORS ENCODING UROCORTIN-2 AND RELATED GENES TO TREAT DIABETES-RELATED CARDIAC DYSFUNCTIONS AND CONGESTIVE HEART FAILURE
#20UROCORTIN-III AND USES THEREOF
#21Formulation comprising a stabilized complex of corticotropin releasing hormone and alpha-2 macroglobulin
#22SYSTEMIC DELIVERY OF VIRUS VECTORS ENCODING UROCORTIN-2 AND RELATED GENES TO TREAT DIABETES-RELATED CARDIAC DYSFUNCTIONS AND CONGESTIVE HEART FAILURE
#23UROCORTIN 2 ANALOGS AND USES THEREOF
#24Urocortin 2 analogs and uses thereof
#25Intranasal administration
#26SYSTEMIC DELIVERY AND REGULATED EXPRESSION OF PARACRINE GENES FOR CARDIOVASCULAR DISEASES AND OTHER CONDITIONS
#27Agonists and antagonists of the urotensinergic system
#28TREATMENT OF HIV
#29FORMULATION
#30TREATMENT OF HIV
#31MEDICAMENT
#32Method of treating brain injury
#33Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
#34Urocortin-III and uses thereof
#35UROCORTIN 2 ANALOGS AND USES THEREOF
#36Modulating neuromuscular junction density changes in botulinum-toxin treated tissue
#37TREATMENT OF HIV
#38METHOD FOR TREATING HEART FAILURE WITH STRESSCOPIN-LIKE PEPTIDES
#39INTRANASAL ADMINISTRATION
#40Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling
#41METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE USE OF THE TREATMENT OF CANCER
#42Methods of using corticotropin-releasing factor for the use of the treatment of cancer
#43Glucose uptake modulator and method for treating diabetes or diabetic complications
#44METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER
#45Treatment of HIV
#46Urocortin-III and uses thereof
#47METHODS TO TREAT ALZHEIMER'S DISEASE OR OTHER AMYLOID BETA ACCUMULATION ASSOCIATED DISORDERS
#48Medicament
#49Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications
#50Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors
#51Use of CRF receptor agonists for the treatment or Prophylaxis of diseases, for example Neurodegenerative diseases
#52METHOD OF AFFECTING SLEEP AND SLEEP-RELATED BEHAVIORS
#53METHOD OF AFFECTING SLEEP AND SLEEP-RELATED BEHAVIORS
#54Urocortin-III and uses thereof
#55Kits for preparing and delivering purified corticotropin
#56Methods for storing and warming purified corticotropin compositions
#57Methods for storing and warming purified corticotropin compositions
#58Methods for storing and warming purified corticotropin compositions